Several other equities analysts have also issued reports on the company. Jefferies Group raised Tate & Lyle to a buy rating and lowered their price target for the stock from GBX 800 ($11.22) to GBX 750 ($10.52) in a research report on Monday, October 23rd. Shore Capital reaffirmed a hold rating on shares of Tate & Lyle in a research report on Tuesday, January 16th. Deutsche Bank reaffirmed a hold rating and issued a GBX 725 ($10.17) price target on shares of Tate & Lyle in a research report on Friday, November 3rd. Liberum Capital reissued a buy rating and issued a GBX 850 ($11.92) target price on shares of Tate & Lyle in a research report on Tuesday, December 19th. Finally, Credit Suisse Group reissued a neutral rating and issued a GBX 710 ($9.96) target price on shares of Tate & Lyle in a research report on Friday, November 3rd. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of GBX 739.75 ($10.37).
Tate & Lyle (TATE) opened at GBX 582 ($8.16) on Wednesday. The stock has a market capitalization of $2,730.00 and a PE ratio of 1,098.11. Tate & Lyle has a 52-week low of GBX 582 ($8.16) and a 52-week high of GBX 796.50 ($11.17).
Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.